Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.2.9.1, BA.2.11, BA.2.12.1, BA.4 and BA.5. Kimura et al.

Published: 23 August 2022| Version 1 | DOI: 10.17632/8fjp3dpdsw.1
Contributor:
Kei Sato

Description

After the global spread of the SARS-CoV-2 Omicron BA.2, some BA.2 subvariants including BA.2.12.1 and BA.4/5, emerged in multiple countries. Our statistical analysis showed that the effective reproduction numbers of these BA.2 subvariants are greater than that of the original BA.2. Neutralization experiments revealed that the immunity induced by BA.1 and BA.2 infections is less effective against BA.4/5. Cell culture experiments showed that BA.2.12.1 and BA.4/5 replicate more efficiently in human alveolar epithelial cells than BA.2, and particularly, BA.4/5 is more fusogenic than BA.2. We further provided the structure of BA.4/5 spike receptor-binding domain that binds to human ACE2 and considered how the substitutions in BA.4/5 spike play roles in ACE2 binding and immune evasion. Moreover, infection experiments using hamsters indicated that BA.4/5 is more pathogenic than BA.2. Our multiscale investigations suggest that the risk of BA.2 subvariants, particularly BA.4/5, to global health is greater than that of original BA.2.

Files

Steps to reproduce

The computational codes used in the present study are available on the GitHub repository (https://github.com/TheSatoLab/BA.2_related_Omicrons).

Categories

Severe Acute Respiratory Syndrome Coronavirus 2

License